Clinical trial
Validation of Markerless Image Guidance Using Intrafraction Kolovoltage X-ray Imaging Using Implanted Fiducials: Phase I Observational Study of Lung Cancer Radiotherapy
NCT04310891 is registered in ClinicalTrials.gov with Royal North Shore Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Validation of Markerless Image Guidance Using Intrafraction Kolovoltage X-ray Imaging Using Implanted Fiducials: Phase I Observational Study of Lung Cancer Radiotherapy
- Lead sponsor
- Royal North Shore Hospital
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- December 4, 2020
- Completion date
- December 31, 2027
- Enrollment
- 5 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
intrafraction kolovoltage x-ray imaging, lung cancer, markerless image guidance